000 01405 a2200397 4500
005 20250513030338.0
264 0 _c19960118
008 199601s 0 0 eng d
022 _a0167-6997
024 7 _a10.1007/BF02614224
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGonzales-de Léon, C
245 0 0 _aPhase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervix.
_h[electronic resource]
260 _bInvestigational new drugs
_c1995
300 _a73-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xtherapeutic use
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aRemission Induction
650 0 4 _aUterine Cervical Neoplasms
_xdrug therapy
700 1 _aLippman, S M
700 1 _aKudelka, A P
700 1 _aEdwards, C L
700 1 _aKavanagh, J J
773 0 _tInvestigational new drugs
_gvol. 13
_gno. 1
_gp. 73-6
856 4 0 _uhttps://doi.org/10.1007/BF02614224
_zAvailable from publisher's website
999 _c7498579
_d7498579